SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-17-000070
Filing Date
2017-11-07
Accepted
2017-11-07 17:25:34
Documents
97
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq32017.htm 10-Q 2525717
2 EXHIBIT 31.1 exhibit311q32017.htm EX-31.1 14545
3 EXHIBIT 31.2 exhibit312q32017.htm EX-31.2 14580
4 EXHIBIT 32.1 exhibit321q32017.htm EX-32.1 8857
5 EXHIBIT 32.2 exhibit322q32017.htm EX-32.2 8846
  Complete submission text file 0000885590-17-000070.txt   12159196

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrx-20170930.xml EX-101.INS 2690039
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20170930.xsd EX-101.SCH 81086
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20170930_cal.xml EX-101.CAL 142682
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20170930_lab.xml EX-101.LAB 975151
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20170930_pre.xml EX-101.PRE 639476
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20170930_def.xml EX-101.DEF 470228
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 171184472
SIC: 2834 Pharmaceutical Preparations